This essay, written by oncology nurse Karen Leary, Ruth & Raymond Perelman Center for Advanced Medicine, nominates fellow registered nurse and colleague Megan Lackaye for CURE®’s 2019 Extraordinary Healer® Award.
These advancements are changing the way many cancers are being treated.
The results of the most recent survey showed that 46% of patients have experienced a decline in their financial security and ability to pay for their care, and nearly 25% worry that they may lose their insurance as a result of the pandemic.
Distinguishing death with dignity from the right to die movement.
Life after a hysterectomy is one of the many challenges I have had to overcome.
Patients faced with cancer are also faced with tough uphill financial battles, but there are assistance programs that can help.
An Extraordinary Healer essay honoring MARY McMAHON, RN, OCN [THE CANCER INSTITUTE AT ST. FRANCIS HOSPITAL, EAST HILLS, NEW YORK]
Karuppiah Kannan, associate director at Takeda Pharmaceuticals, talks about the progress made in treating myeloma and where the field is going in the future.
As the number of patients and survivors continues to increase, it is important that clinician burnout is handled appropriately, explains Thomas A. Gallo.
“We now have second and third generation cousins of thalidomide that are very useful. So, lenalidomide in combination with rituximab is an effective therapy for mantle cell lymphoma that voids some of these adverse events that I’m talking about,” said Dr. Ian Flinn. Hear more about this treatment in his interview with CURE®.
Despite a national addiction crisis, opioids remain an appropriate choice for treating severe cancer pain.
Two women living with metastatic breast cancer that has spread to the brain describe the tools that are helping to keep them alive.
“For the patients that are nervous about how this is going to end, or what's going to happen, I would say that that's true for them outside of the COVID crisis because that's the same question they have about their cancer,” Dr. Scott A. Irwin said.
Kara Maxwell, instructor, medical oncologist, Basser Research Center for BRCA, University of Pennsylvania, explains how a breast cancer clinical trial works.
Stem cells are cells that seem to have the ability to divide perpetually, but what does that mean in cancer?
Patients treated with Xtandi had higher rates of fatigue and pain than those who were treated with Zytiga and prednisone, resulting in a higher likelihood that they will reduce their treatment dose.
Bone pain is a common symptom that patients with multiple myeloma face, but some may find relief with treatments and exercise.
Many patients who completed the survey felt maintenance therapy would help them buy time.
Gary Shelton, Ph.D., coordinator of supportive oncology services at NYU Langone Medical Center, dispels the myth that being referred to palliative care means a patient is nearing end of life.
A nonprofit's new website section offers resources to caregivers of people with lung cancer.
Even though my wife became quadriplegic after her breast cancer progressed, our insurance still did not help us out, so I became her caregiver full-time.
As we enter the holiday season, we know that quality time spent connecting with family is upon us. Even if your gatherings are virtual this year, we encourage you to bring up your family medical history and support each other in understanding your family’s risk factors for colorectal cancer.
An Extraordinary Healer essay honoring LIDICE CEA, LVN [CANCER CENTER AND BREAST CENTER OU
Saketh Guntupalli, M.D., gynecologic oncologist at the University of Colorado Hospital, discusses ways that women can improve intimacy after an ovarian cancer diagnosis.